Evidence map›Paper›PMID 31271824›Full record

ArticleInternational journal of radiation oncology, biology, physics2019

Fasting Reduces Intestinal Radiotoxicity, Enabling Dose-Escalated Radiation Therapy for Pancreatic Cancer.

Marimar de la Cruz Bonilla, Kristina M Stemler, Sabrina Jeter-Jones, Tara N Fujimoto, Jessica Molkentine, Gabriela M Asencio Torres, Xiaomei Zhang, Russell R Broaddus, Cullen M Taniguchi, Helen Piwnica-Worms

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Fasting primes small intestinal regeneration after damage via a microbiome-metabolite-chromatin axis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Cell plasticity in regeneration in the stomach and beyond.Current opinion in genetics & development · 2022
    Review
  12. Nutritional Regulation of Mammary Tumor Microenvironment.Frontiers in cell and developmental biology · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marimar de la Cruz BonillaDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kristina M StemlerDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Sabrina Jeter-JonesDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tara N FujimotoDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Jessica MolkentineDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Gabriela M Asencio TorresDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Xiaomei ZhangDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Russell R BroaddusDepartment of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Cullen M TaniguchiDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: ctaniguchi@mdanderson.org.
Helen Piwnica-WormsDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: hpiwnica-worms@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical TranslationR01CA207236 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PIWNICA-WORMS, HELEN M · 2017 to 2021
$2.4M
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic CancerR01CA227517 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOONG, ALBERT · 2019 to 2023
$2.3M
Training Grant in Cancer BiologyT32CA186892 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KALLURI, RAGHU · 2016 to 2020
$1.1M
Elucidating the Role of Fasting in GI Radioprotection: Applications in Pre-Clinical Pancreatic Cancer ModelF31CA210631 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DE LA CRUZ BONILLA, MARIMAR · 2017 to 2018
$58k
NCI NIH HHS F31 CA210631NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA207236NCI NIH HHS R01 CA227517NCI NIH HHS T32 CA186892NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300
6 · The paper itself

Abstract

purposeChemotherapy combined with radiation therapy is the most commonly used approach for treating locally advanced pancreatic cancer. The use of curative doses of radiation in this disease setting is constrained because of the close proximity of the head of the pancreas to the duodenum. The purpose of this study was to determine whether fasting protects the duodenum from high-dose radiation, thereby enabling dose escalation for efficient killing of pancreatic tumor cells. METHODS AND MATERIALS: C57BL/6J mice were either fed or fasted for 24 hours and then exposed to total abdominal radiation at 11.5 Gy. Food intake, body weight, overall health, and survival were monitored. Small intestines were harvested at various time points after radiation, and villi length, crypt depth, and number of crypts per millimeter of intestine were determined. Immunohistochemistry was performed to assess apoptosis and double-strand DNA breaks, and microcolony assays were performed to determine intestinal stem cell regeneration capacity. A syngeneic KPC model of pancreatic cancer was used to determine the effects of fasting on the radiation responses of both pancreatic cancer and host intestinal tissues.

resultsWe demonstrated that a 24-hour fast in mice improved intestinal stem cell regeneration, as revealed by microcolony assay, and improved host survival of lethal doses of total abdominal irradiation compared with fed controls. Fasting also improved survival of mice with orthotopic pancreatic tumors subjected to lethal abdominal radiation compared with controls with free access to food. Furthermore, fasting did not affect tumor cell killing by radiation therapy and enhanced γ-H2AX staining after radiation therapy, suggesting an additional mild radiosensitizing effect.

conclusionsThese results establish proof of concept for fasting as a dose-escalation strategy, enabling ablative radiation in the treatment of unresectable pancreatic cancer.

Indexed as

FastingOrgan Sparing TreatmentsRadiation ToleranceAbdomenAnimalsApoptosisCell Line, TumorDNA Breaks, Double-StrandedDuodenumFemaleHistonesIntestine, SmallMaleMaximum Tolerated DoseMiceMice, Inbred C57BLgamma-H2AX protein, mouseHistones

Identifiers

PMID31271824
PMCPMC6754784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.